Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

International Volunteers Join Fight Against Epidemic

CHENGDU, China, Feb. 5, 2020 /PRNewswire/ -- Tongzilin residential community, one of the most concentrated expat communities inChengdu, with about 4,300 expats from more than 30 countries and regions. Thomas Deshors, 26, is one of the international volunteers participating in the investigation in...

2020-02-05 17:50 1024

Year-end Report 2019 Bactiguard Holding AB

STOCKHOLM, Feb. 5, 2020 /PRNewswire/ -- A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard's history. The financial effects of both increased BIP sales and new license revenues clearly show that ou...

2020-02-05 15:39 11135

Visiopharm announces long-term exclusive contract with Marylou Tyler

COPENHAGEN, Denmark, Feb. 5, 2020 /PRNewswire/ -- Visiopharm, the leader in AI-driven digital precision pathology, andMarylou Tyler, industry leader in sales process improvement and bestselling author, announce that they are entering into a long-term exclusive collaboration to implement a scalabl...

2020-02-05 14:00 1077

Bridge Biotherapeutics Acquires a New Drug Development Candidate for Back-Eye Diseases

* Signed a collaboration and license agreement for developing back-eye disease treatments with Konkuk University in the Republic of Korea * A total of 10B KRW deal includes 300M KRW of upfront payment SEONGNAM, South Korea, Feb. 5, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical ...

2020-02-05 13:21 1051

Christian Kinch Resigns as CEO of Bactiguard and is Proposed as New Chairman of the Board. Cecilia Edström Appointed New CEO

STOCKHOLM, Sweden, Feb. 5, 2020 /PRNewswire/ -- Christian Kinch today announced to the Board that he will resign as CEO of Bactiguard Holding AB (publ) after close to 16 years. The Board has appointed CFO and Deputy CEOCecilia Edström as new CEO of Bactiguard andStefan Grass (CMO) as Deputy CEO. ...

2020-02-05 06:38 11075

Happiness Biotech Donated Products Amongst Surging Demand for their Immune Systems Products

NANPING, China, Feb. 4, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company donatedRMB1 million worth of their most popular immune system boosting products t...

2020-02-04 21:33 6732

United Imaging Sends Out More than 100 CT Scanners and X-Ray Machines to Aid Diagnosis of the Coronavirus

HOUSTON, Feb. 4, 2020 /PRNewswire/ -- United Imaging employees across the globe extend our thoughts and condolences to those affected by the coronavirus. To help front-line physicians, nurses, and other healthcare professionals diagnose and treat the coronavirus, United Imaging has donated medica...

2020-02-04 21:00 1316

NCCN Recognizes Progress on World Cancer Day while Highlighting Need for Better Global Access to High-Quality Care

National Comprehensive Cancer Network to address HPV-related cancer prevention and treatment with World Cancer Day fundraiser and at upcoming NCCN 2020 Annual Conference Learn more at NCCN.org/wcd and join the conversation online with hashtags #WorldCancerDay, #IAmAndIWill, and #NCCNGlobal PLYM...

2020-02-04 21:00 700

OneSmart Takes Active Measures to Adapt Business and Support Students in Response to Evolving Situation Associated with Coronavirus Outbreak in China

SHANGHAI, Feb. 4, 2020 /PRNewswire/ -- OneSmart International Education Group Limited (NYSE: ONE) ("OneSmart" or the "Company"), a leading premium K-12 education company inChina, today outlined the active measures it has taken to adapt its business and support students in response to the evolving...

2020-02-04 16:00 12527

Kungl. Vetenskapsakademien: Sjöberg Prize Awarded for Decisive Discoveries About Cell Growth

MALMO, Sweden, Feb. 4, 2020 /PRNewswire/ -- The Royal Swedish Academy of Sciences has decided to award the Sjöberg Prize 2020 ofone million US dollars to Michael Hall andDavid Sabatini. The two researchers have radically changed ideas about cell growth, an important factor in the development of c...

2020-02-04 14:52 809

Bactiguard Makes its First Acquisition by Acquiring Vigilenz

STOCKHOLM, Feb. 4, 2020 /PRNewswire/ -- Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz) in Malaysia. The acquisition strengthens Bactiguard's position in infection control and wound management, a...

2020-02-04 14:34 11320

Samsung Biologics Reports 64% Jump in FY19 Earnings, Sees Global Expansion in 2020

INCHEON, South Korea, Feb. 4, 2020 /PRNewswire/ -- Samsung Biologics, a pharmaceutical Contract Manufacturing Organization (CMO), recorded high for the fiscal year 2019, reporting 30.9% growth in sales at701.6 billion won, and 64.6% growth in operating profit at91.7 billion won compared to the ...

2020-02-04 13:50 951

Studycat Donates Free Use of Its Language Learning Apps for Children in Areas Affected by School Closures

HONG KONG, Feb. 4, 2020 /PRNewswire/ -- Asia-based edtech firm Studycat Limited is donating free use of its award-winning Fun Series language learning apps teaching English ,Chinese , Spanis...

2020-02-04 08:45 3175

Pharmacy Alliance members come together in support of bushfire affected pharmacies & communities

SYDNEY, Feb. 4, 2020 /PRNewswire/ -- Pharmacy Alliance has established a bushfire appeal, aiming to raise$250,000 to support bushfire affected pharmacies in providing free medication and personal care items to their communities. Helen Feng...

2020-02-04 08:15 1349

Pharmacy Alliance members come together in support of bushfire affected pharmacies & communities

China Jo-Jo Drugstores Steps in to Help Combat the 2019 Novel Coronavirus

HANGZHOU, China, Feb. 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services inChina, today an...

2020-02-04 06:00 7433

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

SEATTLE, Feb. 4, 2020 /PRNewswire/ -- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals and Trefoil Therapeutics announce the execution of a manufacturing contract to supply their lead compound TTHX1114. Trefoil is developing products based...

2020-02-04 06:00 1583

Citadel Mobilizes $7.5 Million to Support Coronavirus Relief Efforts in China and the United States

CHICAGO, Feb. 4, 2020 /PRNewswire/ -- The Partners at Citadel and Citadel Securities are supporting the relief efforts in theHubei province and assisting families affected by the Coronavirus. Over $1 million of critical medical supplies have already been procured for the Hubei Xinhua Hospit...

2020-02-04 04:12 2483

Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections

PLYMOUTH MEETING, Pennsylvania, Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory pap...

2020-02-03 21:00 2015

Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies

Increased acceptance of outsourcing clinical trials predicted to propel sector revenues to$71.7 billion by 2024 SANTA CLARA, Calif., Feb. 3, 2020 /PRNewswire/ -- With an overall R&D expenditure of$167 billion in 2018, the global healthcare industry is investing heavily in the development of nove...

2020-02-03 17:01 1329

Demand for CROs Rises to Strike Evolving Clinical Trial Models for Target Therapies

GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma

- Belantamab mafodotin accepted for accelerated assessment by the EMA's Committee for Human Medicinal Products (CHMP) - Submission based on data from the pivotal DREAMM-2 study of immunoconjugate targeting B-cell maturation antigen (BCMA) recently published inThe Lancet Oncology LONDON, Feb. 3,...

2020-02-03 17:00 8988

1 ... 733 734 735736737 738 739 ... 808